Abstract
The objectives of the present study were to investigate impact of covalent or non-covalent bound (−)-epigallocatechin-3-gallate (EGCG) on ovotransferrin (OVT) fibrils. Bound EGCG showed fibril-inhibitory activity in a concentration-dependent manner, and covalent bound EGCG inhibited OVT fibrillation more intensely than an equal amount of non-covalent bound EGCG. Bound EGCG resulted in larger fibril building blocks. Covalent bound EGCG shortened OVT fibrils significantly, and non-covalent bound EGCG induced smaller changes in length of OVT fibrils than covalent bound EGCG. A larger amount of covalent or non-covalent bound EGCG led to shorter OVT fibrils. Covalent bound EGCG did not change thickness of OVT fibrils, while newly emerged thicker fibrils were observed in the presence of non-covalent bound EGCG. Covalent bound EGCG shifted isoelectric point of OVT fibril to lower pHs than non-covalent bound EGCG. Bound EGCG decreased surface hydrophobicity, storage modulus and viscosity of OVT fibrils. OVT fibrils with bound EGCG possessed strong antioxidant capacity. The gastrointestinal digestion result demonstrated that covalent bound EGCG contributed to a higher increase in fibril digestibility than non-covalent bound EGCG.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
